LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS

Abstract: provided are biomarker panels and methods of using oxylipins as biomarkers. some embodiments include methods for treating a patient based on oxylipin measurements obtained in the subject. the oxylipin measurements may be used to inform use of an hsd17b13 inhibitor in the subject.

Inventor(s): Heather Kay Webb HSU, Cindy MCREYNOLDS

CPC Classification: G01N33/92 (involving lipids, e.g. cholesterol {, lipoproteins, or their receptors (steroid hormones )})

Search for rejections for patent application number 20250216407